Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
HaemaLogiX to present final data from anti-KMA CAR-T preclinical studies at AACR 2023-03-28 09:43
BJ Bioscience Announces Clinical Collaboration with MSD to Evaluate BJ-001 in Combination with KEYTRUDA® (pembrolizumab) 2023-03-28 09:19
BioDuro-Sundia Announces Formation of Scientific Advisory Board 2023-03-28 08:30
BIORCHESTRA Pens a Pact Worth up to $861M for Central Nervous System(CNS)-Targeted Polymeric Nanoparticle for Intravenous Delivery of Nucleic Acid Therapies 2023-03-27 20:00
YS Biopharma's PIKA Recombinant COVID-19 Vaccine Demonstrates Superior Antibody Neutralization Responses Compared to Inactivated COVID-19 Vaccine in Phase II Head-to-Head Clinical Study 2023-03-27 18:00
Noul Co. Ltd - The RIGHT Foundation Commences Research and Development for Supporting Malaria Control 2023-03-27 17:34
Pharming announces US FDA approval of Joenja® (leniolisib) as the first and only treatment indicated for APDS 2023-03-25 02:51
ProfoundBio Highlights Broad Antitumor Activity in Preclinical Models and Trial-in-Progress for PRO1184 at AACR 2023 Annual Meeting 2023-03-24 20:00
World TB Day 2023: Illumina and GenoScreen Launch Next Generation Sequencing Innovation to Eliminate Tuberculosis in Africa 2023-03-24 16:07
Brii Biosciences Provides Corporate Update and Reports Full-Year 2022 Financial Results 2023-03-24 13:33
EMA Validates Marketing Authorization Application for Henlius' HANSIZHUANG (Serplulimab) 2023-03-24 08:00
Northumbria Healthcare NHSFT and C-POLAR Technologies combine innovation in widely acclaimed hub 2023-03-23 20:32
AnPac Bio-Medical Science Granted Continued Listing by NASDAQ Hearing Panel, Subject to Meeting the Equity Rule on or before July 12, 2023 2023-03-23 20:00
Everest Medicines Announces Signing of an MOU for Strategic Cooperation with Guangdong Academy of Medical Sciences in Renal Diseases 2023-03-23 17:52
Ascentage Pharma Announces 2022 Annual Results Including Strong Sales of Olverembatinib and Steady Progress in Transition Towards Biopharma 2023-03-23 00:22
Daewoong Pharmaceutical's Envlo to enter the global market in full swing with filing for product license in three ASEAN countries 2023-03-22 21:20
CARsgen Announced 2022 Annual Results and Business Updates 2023-03-22 20:50
Biosion bispecific antibody therapies to be featured at the American Association for Cancer Research (AACR) annual meeting 2023 2023-03-22 20:19
Jacobio announces clinical collaboration to evaluate CD73 monoclonal antibody JAB-BX102 in combination with KEYTRUDA® (pembrolizumab) for patients with cancer 2023-03-22 12:36
3SBio announces 2022 annual results, with revenue rising 7.5% year on year and normalized net profit attributable to parents jumping 25.2% 2023-03-22 11:15
1 118 119 120 121 122 452